ATI RN
ATI Maternal Newborn Final Exam Questions
Extract:
A nurse is caring for a client who is in active labor and notes late decelerations on the fetal monitor.
Question 1 of 5
Which of the following is the priority nursing action?
Correct Answer: D
Rationale: Positioning the client on her side is the priority for late decelerations, as it relieves vena cava compression, improving uteroplacental blood flow and fetal oxygenation.
Extract:
A nurse is preparing to administer liquid mycostatin 600,000 units PO TID. Available is mycostatin 100,000 units/mL.
Question 2 of 5
How many mL should the nurse administer per dose? (Round the answer to the nearest whole number. Use a leading zero if it applies. Do not use a trailing zero.)
Correct Answer: A
Rationale:
To administer 600,000 units with mycostatin at 100,000 units/mL, divide 600,000 by 100,000, yielding 6 mL per dose.
Extract:
A nurse is caring for a client who is 2 hours postpartum following a vaginal birth.
Question 3 of 5
Which of the following findings indicates the client's bladder is distended?
Correct Answer: A
Rationale: A fundus displaced to the right indicates bladder distension, which can push the uterus aside, unlike lochia amount, thirst, or contractions, which are unrelated.
Extract:
A nurse is caring for a client who is in labor and has an epidural anesthesia block. The client's blood pressure is 80/40 mm Hg, and the fetal heart rate is 140/min.
Question 4 of 5
Which of the following is the priority nursing action?
Correct Answer: C
Rationale: Placing the client in a lateral position is the priority for hypotension post-epidural, improving venous return and uteroplacental perfusion, unlike leg elevation, notification, or monitoring.
Extract:
A nurse is caring for a client who has severe preeclampsia and is receiving magnesium sulfate IV at 2 g/hr.
Question 5 of 5
Which of the following findings indicates that it is safe for the nurse to continue the infusion?
Correct Answer: B
Rationale: A respiratory rate of 16/min is within the normal range and indicates no respiratory depression, a critical safety parameter for continuing magnesium sulfate therapy, unlike diminished reflexes or bradycardia, which suggest toxicity.